Treviamet 50mg+500mg Tab x35

Treviamet Tablets 50mg + 500mg is a combination oral antidiabetic medication containing two active ingredients: Sitagliptin (50mg) and Metformin HCl (500mg). It is used to improve blood sugar control in adults with type 2 diabetes mellitus when treatment with a single agent is not sufficient.

By combining a DPP-4 inhibitor (Sitagliptin) with a biguanide (Metformin), this formulation targets multiple pathways to lower blood glucose levels, helping the body increase insulin production and decrease the amount of sugar produced by the liver.

Key Benefits:

– Dual-Action Therapy

– Enhanced Insulin Response

– Reduced Glucose Production

– Convenient Combination

– High-Quality Manufacturing

– Optimized Pack Size

CAUTION: This is a prescription-only medication. It is not for the treatment of type 1 diabetes.